Teladoc Health Past Earnings Performance
Past criteria checks 0/6
Teladoc Health's earnings have been declining at an average annual rate of -26.9%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 26.7% per year.
Key information
-26.9%
Earnings growth rate
-24.5%
EPS growth rate
| Healthcare Services Industry Growth | 7.9% |
| Revenue growth rate | 26.7% |
| Return on equity | -65.1% |
| Net Margin | -37.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Teladoc Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,590 | -982 | 1,328 | 320 |
| 30 Jun 24 | 2,609 | -1,006 | 1,343 | 332 |
| 31 Mar 24 | 2,619 | -233 | 1,371 | 343 |
| 31 Dec 23 | 2,602 | -220 | 1,367 | 349 |
| 30 Sep 23 | 2,580 | -4,002 | 1,380 | 342 |
| 30 Jun 23 | 2,531 | -4,018 | 1,372 | 342 |
| 31 Mar 23 | 2,471 | -7,054 | 1,349 | 333 |
| 31 Dec 22 | 2,407 | -13,660 | 1,301 | 334 |
| 30 Sep 22 | 2,323 | -9,860 | 1,269 | 324 |
| 30 Jun 22 | 2,234 | -9,871 | 1,200 | 319 |
| 31 Mar 22 | 2,144 | -6,904 | 1,143 | 321 |
| 31 Dec 21 | 2,033 | -429 | 1,105 | 312 |
| 30 Sep 21 | 1,862 | -812 | 1,346 | 332 |
| 30 Jun 21 | 1,629 | -763 | 1,205 | 281 |
| 31 Mar 21 | 1,367 | -655 | 1,049 | 224 |
| 31 Dec 20 | 1,094 | -485 | 887 | 165 |
| 30 Sep 20 | 867 | -110 | 443 | 88 |
| 30 Jun 20 | 716 | -95 | 396 | 74 |
| 31 Mar 20 | 606 | -98 | 356 | 68 |
| 31 Dec 19 | 553 | -99 | 339 | 65 |
| 30 Sep 19 | 520 | -105 | 327 | 62 |
| 30 Jun 19 | 493 | -108 | 308 | 60 |
| 31 Mar 19 | 457 | -103 | 287 | 57 |
| 31 Dec 18 | 418 | -97 | 265 | 54 |
| 30 Sep 18 | 372 | -117 | 247 | 51 |
| 30 Jun 18 | 330 | -125 | 226 | 48 |
| 31 Mar 18 | 280 | -115 | 200 | 41 |
| 31 Dec 17 | 233 | -107 | 180 | 34 |
| 30 Sep 17 | 194 | -77 | 150 | 30 |
| 30 Jun 17 | 157 | -75 | 133 | 26 |
| 31 Mar 17 | 139 | -75 | 123 | 23 |
| 31 Dec 16 | 123 | -74 | 114 | 22 |
| 30 Sep 16 | 108 | -75 | 105 | 20 |
| 30 Jun 16 | 96 | -58 | 96 | 18 |
| 31 Mar 16 | 88 | -61 | 94 | 17 |
| 31 Dec 15 | 77 | -58 | 89 | 14 |
| 30 Sep 15 | 68 | -50 | 77 | 12 |
| 30 Jun 15 | 59 | -42 | 67 | 10 |
| 31 Mar 15 | 51 | -29 | 51 | 9 |
| 31 Dec 14 | 44 | -20 | 38 | 8 |
| 31 Dec 13 | 20 | -10 | 17 | 4 |
Quality Earnings: 4LL is currently unprofitable.
Growing Profit Margin: 4LL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4LL is unprofitable, and losses have increased over the past 5 years at a rate of 26.9% per year.
Accelerating Growth: Unable to compare 4LL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4LL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).
Return on Equity
High ROE: 4LL has a negative Return on Equity (-65.11%), as it is currently unprofitable.